214 related articles for article (PubMed ID: 28868050)
21. Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents.
Zeng J; Kamei K; Zheng Y; Nishimura K
Nihon Ishinkin Gakkai Zasshi; 2004; 45(2):101-4. PubMed ID: 15118667
[TBL] [Abstract][Full Text] [Related]
22. Infections caused by fungi of the Scedosporium/Pseudallescheria complex in veterinary species.
Elad D
Vet J; 2011 Jan; 187(1):33-41. PubMed ID: 20580291
[TBL] [Abstract][Full Text] [Related]
23. Scedosporium aurantiacum is as virulent as S. prolificans, and shows strain-specific virulence differences, in a mouse model.
Harun A; Serena C; Gilgado F; Chen SC; Meyer W
Med Mycol; 2010 Nov; 48 Suppl 1():S45-51. PubMed ID: 21067330
[TBL] [Abstract][Full Text] [Related]
24. Pandemic Response Box® library as a source of antifungal drugs against Scedosporium and Lomentospora species.
Rollin-Pinheiro R; Xisto MIDDS; de Castro-Almeida Y; Rochetti VP; Borba-Santos LP; Fontes YDS; Ferreira-Pereira A; Rozental S; Barreto-Bergter E
PLoS One; 2023; 18(2):e0280964. PubMed ID: 36735743
[TBL] [Abstract][Full Text] [Related]
25. Reverse line blot hybridisation screening of Pseudallescheria/Scedosporium species in patients with cystic fibrosis.
Lu Q; van den Ende AH; de Hoog GS; Li R; Accoceberry I; Durand-Joly I; Bouchara JP; Hernandez F; Delhaes L
Mycoses; 2011 Oct; 54 Suppl 3():5-11. PubMed ID: 21995657
[TBL] [Abstract][Full Text] [Related]
26. Multilocus sequence typing of Scedosporium apiospermum and Pseudallescheria boydii isolates from cystic fibrosis patients.
Bernhardt A; Sedlacek L; Wagner S; Schwarz C; Würstl B; Tintelnot K
J Cyst Fibros; 2013 Dec; 12(6):592-8. PubMed ID: 23764085
[TBL] [Abstract][Full Text] [Related]
27. Biofilms formed by
Mello TP; Branquinha MH; Santos ALS
Biofouling; 2020 Mar; 36(3):308-318. PubMed ID: 32401558
[TBL] [Abstract][Full Text] [Related]
28. Identifying the emerging human pathogen Scedosporium prolificans by using a species-specific monoclonal antibody that binds to the melanin biosynthetic enzyme tetrahydroxynaphthalene reductase.
Thornton CR; Ryder LS; Le Cocq K; Soanes DM
Environ Microbiol; 2015 Apr; 17(4):1023-38. PubMed ID: 24684242
[TBL] [Abstract][Full Text] [Related]
29. Human and animal isolates of Pseudallescheria boydii and Scedosporium species, from Melbourne, Australia, 1977-1995.
Maslen M; Peel M
Mycoses; 2011 Sep; 54(5):442-9. PubMed ID: 20492531
[TBL] [Abstract][Full Text] [Related]
30. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Gilgado F; Serena C; Cano J; Gené J; Guarro J
Antimicrob Agents Chemother; 2006 Dec; 50(12):4211-3. PubMed ID: 17015631
[TBL] [Abstract][Full Text] [Related]
31. Surface properties, adhesion and biofilm formation on different surfaces by
Mello TP; Oliveira SSC; Frasés S; Branquinha MH; Santos ALS
Biofouling; 2018 Aug; 34(7):800-814. PubMed ID: 30354689
[TBL] [Abstract][Full Text] [Related]
32. Infections due to Pseudallescheria/Scedosporium species in patients with advanced HIV disease--a diagnostic and therapeutic challenge.
Tammer I; Tintelnot K; Braun-Dullaeus RC; Mawrin C; Scherlach C; Schlüter D; König W
Int J Infect Dis; 2011 Jun; 15(6):e422-9. PubMed ID: 21511507
[TBL] [Abstract][Full Text] [Related]
33. Pathology of hyalohyphomycosis caused by Scedosporium apiospermum (Pseudallescheria boydii): an emerging mycosis.
Tadros TS; Workowski KA; Siegel RJ; Hunter S; Schwartz DA
Hum Pathol; 1998 Nov; 29(11):1266-72. PubMed ID: 9824105
[TBL] [Abstract][Full Text] [Related]
34. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii.
Gilgado F; Cano J; Gené J; Sutton DA; Guarro J
J Clin Microbiol; 2008 Feb; 46(2):766-71. PubMed ID: 18077629
[TBL] [Abstract][Full Text] [Related]
35. The high diversity of Scedosporium and Lomentospora species and their prevalence in human-disturbed areas in Taiwan.
Huang YT; Hung TC; Fan YC; Chen CY; Sun PL
Med Mycol; 2023 Apr; 61(4):. PubMed ID: 37061781
[TBL] [Abstract][Full Text] [Related]
36. Molecular identification tools for sibling species of Scedosporium and Pseudallescheria.
Lackner M; Klaassen CH; Meis JF; van den Ende AH; de Hoog GS
Med Mycol; 2012 Jul; 50(5):497-508. PubMed ID: 22004363
[TBL] [Abstract][Full Text] [Related]
37. Phylogeny and immune evasion: a putative correlation for cerebral Pseudallescheria/Scedosporium infections.
Rainer J; Rambach G; Kaltseis J; Hagleitner M; Heiss S; Speth C
Mycoses; 2011 Oct; 54 Suppl 3():48-55. PubMed ID: 21995663
[TBL] [Abstract][Full Text] [Related]
38. Multilocus Sequence Typing Reveals Extensive Genetic Diversity of the Emerging Fungal Pathogen
Harun A; Kan A; Schwabenbauer K; Gilgado F; Perdomo H; Firacative C; Losert H; Abdullah S; Giraud S; Kaltseis J; Fraser M; Buzina W; Lackner M; Blyth CC; Arthur I; Rainer J; Lira JFC; Artigas JG; Tintelnot K; Slavin MA; Heath CH; Bouchara JP; Chen SCA; Meyer W
Front Cell Infect Microbiol; 2021; 11():761596. PubMed ID: 35024355
[No Abstract] [Full Text] [Related]
39. Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection.
Heath CH; Slavin MA; Sorrell TC; Handke R; Harun A; Phillips M; Nguyen Q; Delhaes L; Ellis D; Meyer W; Chen SC;
Clin Microbiol Infect; 2009 Jul; 15(7):689-93. PubMed ID: 19549223
[TBL] [Abstract][Full Text] [Related]
40. Glycoconjugates and polysaccharides from the Scedosporium/Pseudallescheria boydii complex: structural characterisation, involvement in cell differentiation, cell recognition and virulence.
Lopes LC; da Silva MI; Bittencourt VC; Figueiredo RT; Rollin-Pinheiro R; Sassaki GL; Bozza MT; Gorin PA; Barreto-Bergter E
Mycoses; 2011 Oct; 54 Suppl 3():28-36. PubMed ID: 21995660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
